Doctor profile · Federal record
Dr. Helena Aminov, RN/CDE
Nurse Practitioner · New York, NY
- NPI 1457691529
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 7 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
317 E 17Th St, 7Th Floor
New York, NY 100033804
(212) 420-3949
fax (212) 420-2224
Credentials & registration
- NPI registered
- February 2013 — 13 yrs on file
- Profile last updated
- February 17, 2021
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- New York #F309319
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457691529. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
755
Distinct HCPCS
6
Medicare allowed
$58,261
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 254 | 132 | $3 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 179 | 111 | $175 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 147 | 103 | $124 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 116 | 63 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 43 | 35 | $89 | |
83036 |
Hemoglobin a1c level | 16 | 15 | $10 |
In context: peer comparison
Among 41 peers in New York Nurse Practitioner, average services per provider: 177. This provider delivers 4.3× the peer median.Open Payments
Industry payments received
All-time total
$21
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 1 | $20.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,245
Patients
357
Total drug cost
$879,196
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 161 | 30 | $199,896 |
| Trulicity (Dulaglutide) | Brand | 156 | 32 | $196,664 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 119 | 39 | $55,843 |
| Jardiance (Empagliflozin) | Brand | 108 | 31 | $136,139 |
| Repaglinide | Generic | 105 | 25 | $3,189 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 95 | 36 | $9,669 |
| Novolog Flexpen (Insulin Aspart) | Brand | 82 | 25 | $56,214 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 78 | 36 | $2,099 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 60 | 22 | $47,315 |
| Basaglar Kwikpen U-100 (Insulin Glargine,Hum.Rec.Anlog) | Brand | 58 | 20 | $23,786 |
Hospital affiliations
Frequently asked questions
What is Dr. Helena Aminov's medical specialty?
Dr. Helena Aminov practices Nurse Practitioner in New York, NY.
Where does Dr. Helena Aminov practice?
Dr. Helena Aminov practices at 317 E 17Th St, New York, NY 100033804. Office phone: 2124203949.
What is Dr. Helena Aminov's NPI?
Dr. Helena Aminov's National Provider Identifier (NPI) is 1457691529, issued by NPPES.
Does Dr. Helena Aminov accept Medicare assignment?
Yes. Dr. Helena Aminov accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Helena Aminov commonly perform?
Top Medicare-reported procedures in 2023: Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.